Here are five quick facts:
1. Zacks has a $45 price objective on CONMED stock.
2. On Jan. 14, CONMED shares fell 2.4 percent.
3. The company has a 50-day moving average of $42.10.
4. The 200-day moving average is $48.62.
5. CONMED has a market cap of $1.08 billion.
More articles on devices:
SeaSpine, K2M, Smith & Nephew & more: 19 key notes
DeGen Medical launches Hyper-C Anterior Cervical Plate System: 4 key notes
Medical Compression Systems seeks buyer: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
